Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.95 |
| ▸ | HTR2A | P28223 | 2/20 | 0.67 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.64 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.64 |
| ▸ | HRH1 | P35367 | 4/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.60 |
| ▸ | MAOB | P27338 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7902062 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL5987924 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL7773873 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL783035 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL8499157 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL7865088 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL23070514 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL8499165 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL130279 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL169336 | 1.00 | MAOA (0.95) | MAOAHTR2ACYP2A6SMN1; SMN2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240270970-A1 | METHOD OF MANIPULATING HYDROPHILICITY AND HYDROPHOBICITY OF CONVENTIONAL DYE MOLECULES FOR TRACER APPLICATIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2024-08-15 | — | — | US | claimed |
| US-11999855-B2 | Fluorescent dye molecules having hydrophilicity and hydrophobicity for tracer applications | SAUDI ARABIAN OIL COMPANY (SA) | 2024-06-04 | — | — | US | claimed |
| CN-117603250-A | Method for preparing isocyanate from polycarbonate | 诠达化学股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| US-20230183488-A1 | METHOD OF MANIPULATING HYDROPHILICITY AND HYDROPHOBICITY OF CONVENTIONAL DYE MOLECULES FOR TRACER APPLICATIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-15 | — | — | US | claimed |
| CN-115772312-A | Epoxy resin material and preparation method thereof | 株洲时代新材料科技股份有限公司 | 2023-03-10 | — | — | CN | claimed |
| US-11453738-B2 | Organic-inorganic hybrid material, fabrication process of the same and its starting material | CHANDA CHEMICAL CORP. (TW) | 2022-09-27 | — | — | US | claimed |
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-06-23 | — | — | US | claimed |
| CN-114206967-A | Organic-inorganic hybrid material, preparation method thereof and preparation method of starting material thereof | 诠达化学股份有限公司 | 2022-03-18 | — | — | CN | claimed |
| US-20210070914-A1 | Organic-inorganic hybrid material, fabrication process of the same and its starting material | CHANDA CHEMICAL CORP. (TW) | 2021-03-11 | — | — | US | claimed |
| WO-2021042314-A1 | ORGANIC-INORGANIC HYBRID MATERIAL, PREPARATION METHOD THEREFOR AND METHOD FOR PREPARING STARTING MATERIAL THEREOF | 诠达化学股份有限公司 | 2021-03-11 | — | — | WO | claimed |
| EP-2629889-A2 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | Yeda Research and Development Co. Ltd. (IL) | 2013-08-28 | — | — | EP | claimed |
| US-20120253042-A1 | USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2012-10-04 | — | — | US | claimed |
| WO-2012052996-A2 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2012-04-26 | — | — | WO | claimed |
| EP-1606019-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | The University Court of The University of Aberdeen (GB) | 2005-12-21 | — | — | EP | claimed |
| WO-2004078261-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2004-09-16 | — | — | WO | claimed |
| CN-1343024-A | Organic amine used as additive in electrochemical battery | MERCK PATENT GMBH (DE) | 2002-04-03 | — | — | CN | claimed |
| EP-1132370-A2 | Process for producing n-substituted polyhydroxy nitrogen-containing heterocyles | MONSANTO COMPANY (US) | 2001-09-12 | — | — | EP | claimed |
| US-20010019837-A1 | PROCESS FOR MICROBIALLY OXIDIZING N-SUBSTITUTED GLUCAMINES | GRABNER ROY WALTER (US) | 2001-09-06 | — | — | US | claimed |
| EP-0624652-A1 | Process for producing N-substituted polyhydroxy nitrogen-containing heterocycles | MONSANTO COMPANY (US) | 1994-11-17 | — | — | EP | claimed |
| EP-0477160-A1 | Process for producing N-substituted-1-deoxynojirimycin | MONSANTO COMPANY (US) | 1992-03-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | HCN4, SLC46A1, FES | MAOA 770/4885HTR2A 853/4885CYP2A6 1762/4885 |
| US-20120253042-A1 | USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES | ADH5, ADH1C, ADH1A | MAOA 1880/4885HTR2A 2571/4885CYP2A6 1469/4885 |
| US-11453738-B2 | Organic-inorganic hybrid material, fabrication process of the same and its starting material | INTS9, CA4, INCENP | MAOA 424/4885HTR2A 1977/4885CYP2A6 1449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.